3Guo-Wei Li,Qi-Long Chen,Jian-Tao Jiang,Zhong-Rong Zhao the Department of General Surgery, Second Hospital Xi’an Jiaotong University Xi’an 710004, China.The origin of blood supply for cavernous hemangioma of the liver[J].Hepatobiliary & Pancreatic Diseases International,2003,2(3):367-370. 被引量：9
8Quaia E,Degobbis F,Tona G,et a.Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.Radiol Med,2004,107:155-165.
9Suzuki Y,Fujimoto Y,Hosoki Y,et al.Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonography.Eur J Radiol,2003,48:214-219.
10de Ledinghen V,Laharie D,Lecesne R,et al.Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging?A prospective study of 88 nodules in 34 patients.Eur J Gastroenterol Hepatol,2002,14:159-165.
2Han,G.J.,Lee,N.K.,Kim,S. et al.Septic liver: Clinical relevance of early inhomogeneous enhancement of the liver in patients with acute pyelonephritis[J].Acta Radiologica,2013,54(8):975-980.
3Hundt,W.,LaFougre,C.,Vogtmann,J. et al.Evaluation of contrast medium enhancement and [18F]-FDG uptake of liver metastasis in PET/CT prior to therapy[J].European Journal of Radiology,2012,81(4):652-657.
4Furlan,A.,Marin,D.,Cabassa,P. et al.Enhancement pattern of small hepa- tocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: Intermodality agreement and comparison of diagnostic sensi- tivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines [J].European Journal of Radiology, 2012,81(9)'2099-2105.
